• Subscribe
  • Log In
  • Sign up for email updates
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

The Texas Lawbook

Free Speech, Due Process and Trial by Jury

  • Appellate
  • Bankruptcy
  • Commercial Litigation
  • Corp. Deal Tracker/M&A
  • GCs/Corp. Legal Depts.
  • Firm Management
  • White-Collar/Regulatory
  • Pro Bono/Public Service/D&I

Healthcare Exec Sentenced to 5 ½ Years for Two Fraud Schemes

December 20, 2019 Mark Curriden

A federal judge Thursday sentenced Andrew Hillman, a Dallas healthcare executive, to five and one-half years in prison for his role in two major kickback schemes.

Visiting U.S. District Judge Jack Zouhary also ordered Hillman to pay $3 million in restitution.

The judge said the sentence would have been significantly steeper, except that Hillman has cooperated with federal prosecutors investigating kickback schemes involving the now-defunct Forest Park Medical Center and Nexthealth. He testified in the trial earlier this year against nine defendants in the Forest Park trial.

Last year, Hillman pleaded guilty to conspiracy to pay and receive bribes in the Forest Park kickback scam and money laundering in the Nexthealth scheme. 

According to court documents, Hillman admitted he and his business partner, Seymon Narosov, were paid $190,000 by Forest Park to refer patients to the facility or to surgeons with privileges there. The payments, he admitted, were funneled through a shell entity, Adelaide Business Solutions.

Hillman said he and Narosov submitted phony invoices to conceal the wrongdoing.

Court records show that Hillman admitted that he and others conspired to launder the proceeds of various healthcare fraud offenses related to their pharmacies, resulting in $450 million in fraudulent billings to government and private insurance programs. Among other fraudulent activities, the pharmacies paid illegal kickbacks to doctors and others to generate prescriptions, self-funded patient copays to dupe auditors, and misbranded drugs.

Mark Curriden

Mark Curriden is a lawyer/journalist and founder of The Texas Lawbook. In addition, he is a contributing legal correspondent for The Dallas Morning News.

View Mark’s articles

Email Mark

©2025 The Texas Lawbook.

Content of The Texas Lawbook is controlled and protected by specific licensing agreements with our subscribers and under federal copyright laws. Any distribution of this content without the consent of The Texas Lawbook is prohibited.

If you see any inaccuracy in any article in The Texas Lawbook, please contact us. Our goal is content that is 100% true and accurate. Thank you.

Primary Sidebar

Recent Stories

  • P.S. — Pro Bono Work Honored at State Bar of Texas Annual Meeting
  • Dr Pepper Gets Win Ending $1B Distribution Rights Fight
  • Complications for ‘Die Hard’ Star’s Flight That Netted $1M Award Mostly Upheld by Fourth Court of Appeals
  • DOJ, Boeing Respond to 737 Max Settlement Objections 
  • Merit Street Media Hires Sidley to Lead Bankruptcy

Footer

Who We Are

  • About Us
  • Our Team
  • Contact Us
  • Submit a News Tip

Stay Connected

  • Sign up for email updates
  • Article Submission Guidelines
  • Premium Subscriber Editorial Calendar

Our Partners

  • The Dallas Morning News
The Texas Lawbook logo

1409 Botham Jean Blvd.
Unit 811
Dallas, TX 75215

214.232.6783

© Copyright 2025 The Texas Lawbook
The content on this website is protected under federal Copyright laws. Any use without the consent of The Texas Lawbook is prohibited.